{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:20:47Z","timestamp":1795112447323,"version":"4.10.3"},"reference-count":124,"publisher":"Oxford University Press (OUP)","issue":"39","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of this collaborative document is to provide an update for clinicians on best antithrombotic strategies in patients with aortic and\/or peripheral arterial diseases. Antithrombotic therapy is a pillar of optimal medical treatment for these patients at very high cardiovascular risk. While the number of trials on antithrombotic therapies in patients with aortic or peripheral arterial diseases is substantially smaller than for those with coronary artery disease, recent evidence deserves to be incorporated into clinical practice. In the absence of specific indications for chronic oral anticoagulation due to concomitant cardiovascular disease, a single antiplatelet agent is the basis for long-term antithrombotic treatment in patients with aortic or peripheral arterial diseases. Its association with another antiplatelet agent or low-dose anticoagulants will be discussed, based on patient\u2019s ischaemic and bleeding risk as well therapeutic paths (e.g. endovascular therapy). This consensus document aims to provide a guidance for antithrombotic therapy according to arterial disease localizations and clinical presentation. However, it cannot substitute multidisciplinary team discussions, which are particularly important in patients with uncertain ischaemic\/bleeding balance. Importantly, since this balance evolves over time in an individual patient, a regular reassessment of the antithrombotic therapy is of paramount importance.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehab390","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T07:41:56Z","timestamp":1622792516000},"page":"4013-4024","source":"Crossref","is-referenced-by-count":138,"title":["Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy"],"prefix":"10.1093","volume":"42","author":[{"given":"Victor","family":"Aboyans","sequence":"first","affiliation":[{"name":"Department of Cardiology, Dupuytren University Hospital, and INSERM 1094 & IRD, University of Limoges , 2, Martin Luther King ave, 87042, Limoges,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6192-1741","authenticated-orcid":false,"given":"Rupert","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Klinikum Darmstadt GmbH, Darmstadt Germany, and Center for Thrombosis and Hemostasis, University of Mainz , Mainz,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2022-6440","authenticated-orcid":false,"given":"Lucia","family":"Mazzolai","sequence":"additional","affiliation":[{"name":"Division of Angiology, Heart and Vessel Department, Lausanne University Hospital (CHUV) , Lausanne,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[{"name":"Division of Angiology, Medical University Graz ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7229-9780","authenticated-orcid":false,"given":"Jos\u00e9 F Rodriguez","family":"Palomares","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Vall d\u2019Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f2noma de Barcelona, Centro de Investigaci\u00f3n Biom\u00e9dica en RedCV, CIBER CV , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Debus","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, University Heart Centre Hamburg, University Medical Centre HamburgEppendorf , Hamburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-5347","authenticated-orcid":false,"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, ACTION Study Group (www.actioncoeur.org), INSERM UMRS 1166, Institut de Cardiologie, H\u00f4pital Piti\u00e9Salp\u00eatri\u00e8re (APHP) , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4677-9756","authenticated-orcid":false,"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[{"name":"Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Landeskrankenhaus Feldkirch ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Espinola-Klein","sequence":"additional","affiliation":[{"name":"Section Angiology, Department of Cardiology, Cardiology I, University Medical Center Mainz , Mainz,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5604-6399","authenticated-orcid":false,"given":"Basil S","family":"Lewis","sequence":"additional","affiliation":[{"name":"Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, TechnionIsrael Institute of Technology , Haifa,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-0170","authenticated-orcid":false,"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University Hospitals , Geneva,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0698-2696","authenticated-orcid":false,"given":"Dirk","family":"Sibbing","sequence":"additional","affiliation":[{"name":"Ludwig Maximilians Universit\u00e4t M\u00fcnchen and Privatklinik Lauterbacher M\u00fchle am Ostersee , Munich,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-6288","authenticated-orcid":false,"given":"Henrik","family":"Sillesen","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Rigshospitalet, University of Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Stabile","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples \u2018Federico II\u2019 , Naples,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schlager","sequence":"additional","affiliation":[{"name":"Division of Angiology, 2nd Department of Medicine, Medical University of Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5763-9804","authenticated-orcid":false,"given":"Marco","family":"De Carlo","sequence":"additional","affiliation":[{"name":"Cardiothoracic and Vascular Department, Azienda OspedalieroUniversitaria Pisana , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"2026080909420360800_ehab390-B1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080909420360800_ehab390-B2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.STR.8.3.301","article-title":"Controlled trial of aspirin in cerebral ischemia","volume":"8","author":"Fields","year":"1977","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-123-9-199511010-00002","article-title":"Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group","volume":"123","author":"C\u00f4t\u00e9","year":"1995","journal-title":"Ann Intern Med"},{"key":"2026080909420360800_ehab390-B4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1474-4422(17)30038-8","article-title":"Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial","volume":"16","author":"Amarenco","year":"2017","journal-title":"Lancet Neurol"},{"key":"2026080909420360800_ehab390-B5","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1161\/STROKEAHA.120.032239","article-title":"THALES Steering Committee and Investigators. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin","volume":"51","author":"Amarenco","year":"2020","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.STR.9.4.309","article-title":"Controlled trial of aspirin in cerebral ischemia. Part II: surgical group","volume":"9","author":"Fields","year":"1978","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.STR.19.10.1211","article-title":"Danish very-low-dose aspirin after carotid endarterectomy trial","volume":"19","author":"Boysen","year":"1988","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00000658-199003000-00002","article-title":"Antiplatelet treatment prolongs survival after carotid bifurcation endarterectomy. Analysis of the clinical series followed by a controlled trial","volume":"211","author":"Kretschmer","year":"1990","journal-title":"Ann Surg"},{"key":"2026080909420360800_ehab390-B9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.STR.24.8.1125","article-title":"Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial","volume":"24","author":"Lindblad","year":"1993","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B10","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(99)05388-X","article-title":"Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"key":"2026080909420360800_ehab390-B11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00270-005-5288-y","article-title":"Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting","volume":"29","author":"Dalainas","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026080909420360800_ehab390-B12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"2026080909420360800_ehab390-B13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/STROKEAHA.112.673608","article-title":"The effect of medical treatments on stroke risk in asymptomatic carotid stenosis","volume":"44","author":"King","year":"2013","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24602","article-title":"Comparative effectiveness of prestroke aspirin on stroke severity and outcome","volume":"79","author":"Park","year":"2016","journal-title":"Ann Neurol"},{"key":"2026080909420360800_ehab390-B15","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080909420360800_ehab390-B16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"2026080909420360800_ehab390-B17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/01.WNL.0000110311.09970.83","article-title":"Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies","volume":"62","author":"Lovett","year":"2004","journal-title":"Neurology"},{"key":"2026080909420360800_ehab390-B18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE)","volume":"348","author":"Committee","year":"1996","journal-title":"Lancet"},{"key":"2026080909420360800_ehab390-B19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1474-4422(06)70685-8","article-title":"Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial","volume":"6","author":"Halkes","year":"2007","journal-title":"Lancet Neurol"},{"key":"2026080909420360800_ehab390-B20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/STROKEAHA.111.637686","article-title":"Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Geeganage","year":"2012","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B21","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial","volume":"111","author":"Markus","year":"2005","journal-title":"Circulation"},{"key":"2026080909420360800_ehab390-B22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/ijs.12050","article-title":"Effect of addition of clopidogrel to aspirin on stroke incidence: meta-analysis of randomized trials","volume":"10","author":"Palacio","year":"2015","journal-title":"Int J Stroke"},{"key":"2026080909420360800_ehab390-B23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1474-4422(10)70060-0","article-title":"Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial","volume":"9","author":"Wong","year":"2010","journal-title":"Lancet Neurol"},{"key":"2026080909420360800_ehab390-B24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Johnston","year":"2020","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\"AICLA\" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B28","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.STR.21.8.1122","article-title":"European Stroke Prevention Study","volume":"21","year":"1990","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"2026080909420360800_ehab390-B30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejvs.2016.10.011","article-title":"Systematic review and meta-analysis of dual versus single antiplatelet therapy in carotid interventions","volume":"53","author":"Barkat","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026080909420360800_ehab390-B31","doi-asserted-by":"crossref","first-page":"e1355","DOI":"10.1097\/MD.0000000000001355","article-title":"Is extended duration of dual antiplatelet therapy after carotid stenting beneficial?","volume":"94","author":"Jhang","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"2026080909420360800_ehab390-B32","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jvs.2013.09.011","article-title":"Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis","volume":"59","author":"Nakagawa","year":"2014","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/01616412.2017.1301042","article-title":"Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting","volume":"39","author":"Nakagawa","year":"2017","journal-title":"Neurol Res"},{"key":"2026080909420360800_ehab390-B34","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jvs.2018.01.063","article-title":"Different perioperative antiplatelet therapies for patients treated with carotid endarterectomy in routine practice","volume":"68","author":"Zimmermann","year":"2018","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B35","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/STROKEAHA.111.000798","article-title":"Urgent best medical therapy may obviate the need for urgent surgery in patients with symptomatic carotid stenosis","volume":"44","author":"Shahidi","year":"2013","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B36","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","article-title":"Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol"},{"key":"2026080909420360800_ehab390-B37","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jvs.2015.12.020","article-title":"Dual antiplatelet therapy reduces stroke but increases bleeding at the time of carotid endarterectomy","volume":"63","author":"Jones","year":"2016","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B38","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/01.CIR.0000121739.05643.E6","article-title":"Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy","volume":"109","author":"Payne","year":"2004","journal-title":"Circulation"},{"key":"2026080909420360800_ehab390-B39","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jvs.2013.10.087","article-title":"Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease","volume":"59","author":"Alcocer","year":"2014","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1708538113478763","article-title":"Combined clopidogrel and aspirin therapy in patients undergoing carotid endarterectomy is associated with an increased risk of postoperative bleeding","volume":"21","author":"Hale","year":"2013","journal-title":"Vascular"},{"key":"2026080909420360800_ehab390-B41","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jvs.2013.05.092","article-title":"Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery","volume":"58","author":"Saadeh","year":"2013","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1258\/vasc.2011.oa0336","article-title":"Blood loss and complications following carotid endarterectomy in patients treated with clopidogrel","volume":"20","author":"Chechik","year":"2012","journal-title":"Vascular"},{"key":"2026080909420360800_ehab390-B43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jvs.2011.03.003","article-title":"Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery","volume":"54","author":"Stone","year":"2011","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B44","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/STROKEAHA.112.669929","article-title":"Stroke risk after posterior circulation stroke\/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies","volume":"44","author":"Gulli","year":"2013","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amjmed.2016.12.027","article-title":"Subclavian Artery Disease: diagnosis and Therapy","volume":"130","author":"Saha","year":"2017","journal-title":"Am J Med"},{"key":"2026080909420360800_ehab390-B46","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jacc.2018.12.075","article-title":"vascular inflammation in subclinical atherosclerosis detected by hybrid PET\/MRI","volume":"73","author":"Fern\u00e1ndez-Friera","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080909420360800_ehab390-B47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.echo.2014.11.015","article-title":"Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance","volume":"28","author":"Goldstein","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080909420360800_ehab390-B48","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jacc.2004.05.075","article-title":"Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study","volume":"44","author":"Meissner","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080909420360800_ehab390-B49","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199605093341902","article-title":"Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke","volume":"334","author":"Amarenco","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"2026080909420360800_ehab390-B51","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/CIRCULATIONAHA.108.811935","article-title":"Aortic arch plaques and risk of recurrent stroke and death","volume":"119","author":"Di Tullio","year":"2009","journal-title":"Circulation"},{"key":"2026080909420360800_ehab390-B52","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/STROKEAHA.113.004251","article-title":"Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques","volume":"45","author":"Amarenco","year":"2014","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B53","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"2026080909420360800_ehab390-B54","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B55","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B56","first-page":"450","article-title":"The effect of ticagrelor on growth of small abdominal aortic aneurysms \u2013 a randomized controlled trial","volume":"116","author":"Wanhainen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026080909420360800_ehab390-B57","doi-asserted-by":"crossref","first-page":"e181281","DOI":"10.1001\/jamanetworkopen.2018.1281","article-title":"Association of mortality and acute aortic events with ascending aortic aneurysm: a systematic review and meta-analysis","volume":"1","author":"Guo","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2026080909420360800_ehab390-B58","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jvs.2019.03.057","article-title":"Systematic review and meta-analysis of the association between intraluminal thrombus volume and abdominal aortic aneurysm rupture","volume":"70","author":"Singh","year":"2019","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.avsg.2016.07.066","article-title":"Management of modifiable vascular risk factors improves late survival following abdominal aortic aneurysm repair: a systematic review and meta-analysis","volume":"39","author":"Khashram","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"2026080909420360800_ehab390-B60","doi-asserted-by":"crossref","first-page":"43079","DOI":"10.1038\/srep43079","article-title":"Parenteral administration of factor Xa\/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis","volume":"7","author":"Moran","year":"2017","journal-title":"Sci Rep"},{"key":"2026080909420360800_ehab390-B61","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mva.2002.126087","article-title":"Effect of intraluminal thrombus on wall stress in patient-specific models of abdominal aortic aneurysm","volume":"36","author":"Wang","year":"2002","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.21037\/cdt.2017.07.01","article-title":"Warfarin anticoagulation in acute type A aortic dissection survivors (WATAS)","volume":"7","author":"von Kodolitsch","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026080909420360800_ehab390-B63","doi-asserted-by":"crossref","first-page":"A2074","DOI":"10.1016\/S0735-1097(18)32615-9","article-title":"Anticoagulation therapy following acute aortic dissection","volume":"71","author":"Bismuth","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080909420360800_ehab390-B64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1157\/13099468","article-title":"Intramural aortic hematoma and anticoagulation","volume":"60","author":"Ca\u00f1adas","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"2026080909420360800_ehab390-B65","first-page":"56","article-title":"Aortic intramural haematoma and chronic anticoagulation: role of transoesophageal echocardiography","volume":"9","author":"Ruggiero","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"2026080909420360800_ehab390-B66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/SLA.0000000000000612","article-title":"Results and factors affecting early outcome of fenestrated and\/or branched stent grafts for aortic aneurysms: a multicenter prospective study","volume":"261","author":"Marzelle","year":"2015","journal-title":"Ann Surg"},{"key":"2026080909420360800_ehab390-B67","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejvs.2016.05.013","article-title":"The endovascular sealing device in combination with parallel grafts for treatment of juxta\/suprarenal abdominal aortic aneurysms: short-term results of a novel alternative","volume":"52","author":"De Bruin","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026080909420360800_ehab390-B68","first-page":"2321","article-title":"Safety and necessity of antiplatelet therapy on patients underwent endovascular aortic repair with both Stanford type B aortic dissection and coronary heart disease","volume":"130","author":"He","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"2026080909420360800_ehab390-B69","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jvs.2014.12.044","article-title":"Early endovascular aneurysm repair after percutaneous coronary interventions","volume":"61","author":"Pecoraro","year":"2015","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B70","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejvs.2013.12.009","article-title":"Safety of chronic anticoagulation therapy after endovascular abdominal aneurysm repair (EVAR)","volume":"47","author":"De Rango","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026080909420360800_ehab390-B71","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/152660280100800406","article-title":"Thrombus formation in aortic endografts","volume":"8","author":"Wegener","year":"2001","journal-title":"J Endovasc Ther"},{"key":"2026080909420360800_ehab390-B72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejvs.2015.01.020","article-title":"Should I treat asymptomatic thrombus lining an EVAR Stent Graft Limb detected during surveillance imaging and, if so, how?","volume":"50","author":"Oliveira","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026080909420360800_ehab390-B73","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jvir.2008.08.007","article-title":"Mural thrombotic deposits in abdominal aortic endografts are common and do not require additional treatment at short-term and midterm follow-up","volume":"19","author":"Maleux","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"2026080909420360800_ehab390-B74","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ"},{"key":"2026080909420360800_ehab390-B75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"Fowkes","year":"2010","journal-title":"JAMA"},{"key":"2026080909420360800_ehab390-B76","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B77","first-page":"1706","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","author":"Anand","year":"2007","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B78","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.112.000679","article-title":"Vorapaxar in patients with peripheral artery disease: results from TRA2\u00b0P-TIMI 50","volume":"127","author":"Bonaca","year":"2013","journal-title":"Circulation"},{"key":"2026080909420360800_ehab390-B79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B80","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B81","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70130-2","article-title":"Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure","volume":"28","author":"Sarac","year":"1998","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Dutch Bypass Oral anticoagulants or Aspirin (BOA) Study Group. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"2026080909420360800_ehab390-B83","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jvs.2008.02.062","article-title":"Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions","volume":"48","author":"Iida","year":"2008","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B85","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy \u2013 the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"2026080909420360800_ehab390-B86","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1526602818760488","article-title":"Edoxaban plus aspirin vs dual antiplatelet therapy in endovascular treatment of patients with peripheral artery disease: results of the ePAD trial","volume":"25","author":"Moll","year":"2018","journal-title":"J Endovasc Ther"},{"key":"2026080909420360800_ehab390-B87","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080909420360800_ehab390-B88","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B89","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.119.039773","article-title":"Acute limb ischemia in peripheral artery disease","volume":"140","author":"Hess","year":"2019","journal-title":"Circulation"},{"key":"2026080909420360800_ehab390-B90","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B91","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.046448","article-title":"The role of combination antiplatelet and anticoagulation therapy in diabetes and cardiovascular disease: insights from the COMPASS trial","volume":"141","author":"Bhatt","year":"2020","journal-title":"Circulation"},{"key":"2026080909420360800_ehab390-B92","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026080909420360800_ehab390-B93","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1177\/2047487319846999","article-title":"Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery","volume":"26","author":"Venermo","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080909420360800_ehab390-B94","first-page":"CD000536","article-title":"Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery","volume":"2011","author":"Geraghty","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080909420360800_ehab390-B95","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jvs.2007.07.046","article-title":"The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure","volume":"46","author":"Brumberg","year":"2007","journal-title":"J Vasc Surg"},{"key":"2026080909420360800_ehab390-B96","first-page":"CD002071","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","volume":"2012","author":"Robertson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080909420360800_ehab390-B97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1024\/0301-1526\/a000676","article-title":"Antithrombotic treatment in peripheral artery disease","volume":"47","author":"Olinic","year":"2018","journal-title":"Vasa"},{"key":"2026080909420360800_ehab390-B98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2013.10.027","article-title":"Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: differences between peripheral and coronary angioplasty","volume":"232","author":"Gremmel","year":"2014","journal-title":"Atherosclerosis"},{"key":"2026080909420360800_ehab390-B99","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.jcin.2019.08.006","article-title":"Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease","volume":"12","author":"Cho","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080909420360800_ehab390-B100","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety","volume":"142","author":"Hiatt","year":"2020","journal-title":"Circulation"},{"key":"2026080909420360800_ehab390-B101","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.avsg.2019.02.022","article-title":"The use of antithrombotics is not beneficial for conservative management of spontaneous isolated dissection of the superior mesenteric artery: a meta-analysis","volume":"60","author":"Ahn","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"2026080909420360800_ehab390-B102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1531003507313220","article-title":"Antiplatelet therapy for vascular interventions","volume":"20","author":"Comerota","year":"2008","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"key":"2026080909420360800_ehab390-B103","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/14656566.2017.1285905","article-title":"Lipid and other management to improve arterial disease and survival in end stage renal disease","volume":"18","author":"Dimmitt","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"2026080909420360800_ehab390-B104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13075-018-1790-x","article-title":"Clinical course and prognostic factors of childhood Takayasu's arteritis: over 15-year comprehensive analysis of 101 patients","volume":"21","author":"Fan","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2026080909420360800_ehab390-B105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10157-016-1308-2","article-title":"Dual antiplatelet and anticoagulant APAC prevents experimental ischemia-reperfusion-induced acute kidney injury","volume":"21","author":"Tuuminen","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"2026080909420360800_ehab390-B106","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.jacc.2014.03.039","article-title":"Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study","volume":"63","author":"Lamberts","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080909420360800_ehab390-B107","doi-asserted-by":"crossref","first-page":"e007452","DOI":"10.1161\/JAHA.117.007452","article-title":"Association of peripheral artery disease with incident atrial fibrillation: the ARIC (Atherosclerosis Risk in Communities) study","volume":"7","author":"Bekwelem","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026080909420360800_ehab390-B108","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijcard.2015.06.094","article-title":"Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease","volume":"199","author":"Wasmer","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080909420360800_ehab390-B109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2010.03.003","article-title":"Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) registry","volume":"40","author":"Winkel","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026080909420360800_ehab390-B110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/eurheartj\/eht492","article-title":"Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF","volume":"35","author":"Jones","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080909420360800_ehab390-B111","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ehjcvp\/pvz047","article-title":"Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease","volume":"6","author":"Coleman","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026080909420360800_ehab390-B112","doi-asserted-by":"crossref","first-page":"e004699","DOI":"10.1161\/JAHA.116.004699","article-title":"Efficacy and safety of apixaban compared with warfarin in patients with atrial fibrillation and peripheral artery disease: insights from the ARISTOTLE trial","volume":"6","author":"Hu","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026080909420360800_ehab390-B113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ehjcvp\/pvz072","article-title":"Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease","volume":"7","author":"Lee","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026080909420360800_ehab390-B114","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080909420360800_ehab390-B115","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080909420360800_ehab390-B116","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1093\/eurheartj\/ehz732","article-title":"Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials","volume":"40","author":"Gargiulo","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080909420360800_ehab390-B117","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1538-7836.2011.04437.x","article-title":"Differential propensity for major hemorrhagic events in patients with different types of arterial disease","volume":"9","author":"Achterberg","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2026080909420360800_ehab390-B118","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehq021","article-title":"Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis","volume":"31","author":"Ducrocq","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080909420360800_ehab390-B119","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1526602819866191","article-title":"A new preprocedural score to predict bleeding complications of endovascular interventions for peripheral artery disease","volume":"26","author":"Spiliopoulos","year":"2019","journal-title":"J Endovasc Ther"},{"key":"2026080909420360800_ehab390-B120","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","article-title":"Validation of high bleeding risk criteria and definition as proposed by the Academic Research Consortium for High Bleeding Risk","volume":"41","author":"Corpataux","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080909420360800_ehab390-B121","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/eurheartj\/ehz404","article-title":"Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial","volume":"40","author":"de Vries","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080909420360800_ehab390-B122","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1055\/s-0038-1646923","article-title":"Predictors of bleeding in patients with symptomatic peripheral artery disease: a cohort study using the Health Improvement Network in the United Kingdom","volume":"118","author":"Cea Soriano","year":"2018","journal-title":"Thromb Haemost"},{"key":"2026080909420360800_ehab390-B123","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ahj.2019.11.007","article-title":"Major bleeding in patients with peripheral artery disease: insights from the EUCLID trial","volume":"220","author":"Ward","year":"2020","journal-title":"Am Heart J"},{"key":"2026080909420360800_ehab390-B124","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2019.04.041","article-title":"Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and\/or aspirin in a randomized, double-blind, placebo-controlled trial","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/39\/4013\/60913251\/ehab390.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/39\/4013\/60913251\/ehab390.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T13:42:22Z","timestamp":1786282942000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/39\/4013\/6323985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":124,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2021,7,19]]},"published-print":{"date-parts":[[2021,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab390","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,14]]},"published":{"date-parts":[[2021,7,19]]}}}